Tech Company Financing Transactions
Drug Hunter Funding Round
Drug Hunter secured a Seed venture capital round on 9/15/2025. Investors included Teamworthy Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/15/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Teamworthy Ventures (Lead Investor) (Thomas Lehrman)
Proceeds Purpose
The funding will accelerate Drug Hunter's mission to empower scientists and R&D leaders with the insights they need to confidently discover tomorrow's medicines.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boston, TN Undisclosed
USA
Boston, TN Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Drug Hunter is the essential knowledge platform for R&D organizations turning molecules into medicines. Drug Hunter's experts keep you current by connecting the dots, distilling industry lessons from thousands of sources into a one-of-a-kind searchable platform for drug discovery knowledge you can apply to make better decisions and solve critical discovery challenges.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Hu
Browse more venture capital transactions:
Prev: 9/15/2025: Helius Medical Technologies venture capital transaction
Next: 9/15/2025: Arch venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs